Literature DB >> 16449351

Genetic restoration of aldose reductase to the collecting tubules restores maturation of the urine concentrating mechanism.

James Y Yang1, W Y Tam, Sidney Tam, Hong Guo, Xiaochun Wu, Guohua Li, Jenny F L Chau, Janet D Klein, Sookja K Chung, Jeff M Sands, Stephen S M Chung.   

Abstract

To investigate the underlying causes for aldose reductase deficiency-induced diabetes insipidus, we carried out studies with three genotypic groups of mice. These included wild-type mice, knockout mice, and a newly created bitransgenic line that was homozygous for both the aldose reductase null mutation and an aldose reductase knockin transgene driven by the kidney-specific cadherin promoter to direct transgene expression in the collecting tubule epithelial cells. We found that from early renal developmental stages onward, urine osmolality did not exceed 1,000 mosmol/kgH2O in aldose reductase-deficient mice. The functional defects were correlated with significant renal cellular and structural abnormalities that included cell shrinkage, apoptosis, disorganized tubular and vascular structures, and segmental atrophy. In contrast, the transgenic aldose reductase expression in the bitransgenic mice largely but incompletely rescued urine concentrating capacity and significantly improved renal cell survival, cellular morphology, and renal structures. Together, these results suggest that aldose reductase not only plays important roles in osmoregulation and medullary cell survival but may also be essential for the full maturation of the urine concentrating mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449351     DOI: 10.1152/ajprenal.00506.2005

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  7 in total

Review 1.  Transgenic mice and their impact on kidney research.

Authors:  Isabelle Rubera; Edith Hummler; Friedrich Beermann
Journal:  Pflugers Arch       Date:  2008-12-16       Impact factor: 3.657

2.  Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice.

Authors:  Sanjay Srivastava; Elena Vladykovskaya; Oleg A Barski; Matthew Spite; Karin Kaiserova; J Mark Petrash; Stephen S Chung; Greg Hunt; Buddhadeb Dawn; Aruni Bhatnagar
Journal:  Circ Res       Date:  2009-09-03       Impact factor: 17.367

3.  Tonicity-responsive microRNAs contribute to the maximal induction of osmoregulatory transcription factor OREBP in response to high-NaCl hypertonicity.

Authors:  Weifeng Huang; Huili Liu; Tao Wang; Tiantian Zhang; Juntao Kuang; Yu Luo; Stephen S M Chung; Li Yuan; James Y Yang
Journal:  Nucleic Acids Res       Date:  2010-09-17       Impact factor: 16.971

4.  Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 mice.

Authors:  H Liu; Y Luo; T Zhang; Y Zhang; Q Wu; L Yuan; S S M Chung; P J Oates; J Y Yang
Journal:  Diabetologia       Date:  2011-01-27       Impact factor: 10.122

Review 5.  The betaine/GABA transporter and betaine: roles in brain, kidney, and liver.

Authors:  Stephen A Kempson; Yun Zhou; Niels C Danbolt
Journal:  Front Physiol       Date:  2014-04-24       Impact factor: 4.566

6.  Aldo keto reductase 1B7 and prostaglandin F2alpha are regulators of adrenal endocrine functions.

Authors:  Sarah Lambert-Langlais; Jean-Christophe Pointud; Anne-Marie Lefrançois-Martinez; Fanny Volat; Michèle Manin; François Coudoré; Pierre Val; Isabelle Sahut-Barnola; Bruno Ragazzon; Estelle Louiset; Catherine Delarue; Hervé Lefebvre; Yoshihiro Urade; Antoine Martinez
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

7.  Aldose reductase interacts with AKT1 to augment hepatic AKT/mTOR signaling and promote hepatocarcinogenesis.

Authors:  Jia-Xing Zhao; Ya-Wei Yuan; Cheng-Fu Cai; Dong-Yan Shen; Mao-Li Chen; Feng Ye; Yan-Jun Mi; Qi-Cong Luo; Wang-Yu Cai; Wei Zhang; Ying Long; Yong Zeng; Guo-Dong Ye; Shu-Yu Yang
Journal:  Oncotarget       Date:  2017-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.